GGrantIndex
Sort

64,565 grants matching drug discovery

University of Michigan Proteogenomics Data Analysis Center

$831,340
Alexey I Nesvizhskii · University Of Michigan At Ann Arbor · U24 · FY2017 · CA

University of Michigan Proteogenomics Data Analysis Center

$831,340
Alexey I Nesvizhskii · University Of Michigan At Ann Arbor · U24 · FY2016 · CA

The Physiology of Store-Operated Channels in the Nervous System

$831,293
Murali Prakriya · Northwestern University At Chicago · R35 · FY2023 · NS

Inhibition Of Renal Injury

$831,292
Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK

Precision Phenomics to Personalize Drug Therapy (P3DT)

$831,119
Joshua C. Denny · Vanderbilt University Medical Center · P50 · FY2019 · GM

Interdepartmental Biotechnology Training Program

$830,954
Karl D Wittrup · Massachusetts Institute Of Technology · T32 · FY2010 · GM

Genetic Susceptibility To Carcinogens and Toxicants

$830,841
Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES

The Integrative Genomics of Acute Asthma Control

$830,650
Benjamin Alexander Raby · Brigham And Women'S Hospital · R01 · FY2017 · HL

Investigating Laser-Activation of Structured Polymer Materials for Drug Delivery

$830,611
Eric Mazur · Harvard University · · FY2018 · MPS

Pharmacokinetics of Long-Acting Preparations of Antitubercular Drugs in Rodents

$830,604
Maria Arolfo · Sri International · N01 · FY2025 · AI

cGAS inhibitors for Alzheimer's disease treatment

$830,547
Subhash C Sinha · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AG

Developing small molecule therapeutics for Ebola hemorrhagic fever virus

$830,518
Arnab Basu · Microbiotix, Inc · R01 · FY2012 · AI

NATIONAL BIOMEDICAL COMPUTATION RESOURCE

$830,496
Rommie E Amaro · University Of California, San Diego · P41 · FY2019 · GM

Group II mGluR antagonists and negative modulators in depression

$830,492
Athina Markou · University Of California, San Diego · R01 · FY2013 · MH

Children's Oncology Group Statistics and Data Center

$830,139
Todd A Alonzo · Public Health Institute · U10 · FY2020 · CA

Bridging pharmacodynamic biomarkers to clinical outcomes in pediatric inflammatory diseases

$830,032
John N Van Den Anker · Children'S Research Institute · U54 · FY2018 · HD

Biodiversity of Vietnam and Laos

$830,025
Djaja D Soejarto · University Of Illinois At Chicago · U01 · FY2006 · TW

NOVEL PARADIGMS FOR DRUG DISCOVERY: COMPUTATIONAL MULTITARGET SCREENING

$830,000
Ram Samudrala · University Of Washington · DP1 · FY2010 · OD

Antidotes to Anthrax Lethal Factor Intoxication

$830,000
Alan Thomas Johnson · Panthera Biopharma, Llc · U01 · FY2008 · AI

Disease-Specific Integrated Microphysiological Human Tissue Models

$829,891
Kevin E Healy · University Of California Berkeley · UH3 · FY2014 · TR

Identification of Common Genetic Variants for Atrial Fibrillation and PR Interval

$829,831
Patrick Thomas Ellinor · Massachusetts General Hospital · R01 · FY2014 · HL

MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies

$829,650
Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2020 · CA

MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies

$829,650
Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2021 · CA

MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies

$829,650
Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2019 · CA

MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies

$829,650
Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2018 · CA